GB1398724A - Disubstituted xanthone carboxylic acid compounds - Google Patents

Disubstituted xanthone carboxylic acid compounds

Info

Publication number
GB1398724A
GB1398724A GB4737374A GB4737374A GB1398724A GB 1398724 A GB1398724 A GB 1398724A GB 4737374 A GB4737374 A GB 4737374A GB 4737374 A GB4737374 A GB 4737374A GB 1398724 A GB1398724 A GB 1398724A
Authority
GB
United Kingdom
Prior art keywords
alkyl
product
carboxylic acid
cycloalkyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4737374A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00217287A external-priority patent/US3849565A/en
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of GB1398724A publication Critical patent/GB1398724A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

1398724 Disubstituted xanthone-carboxylic acid compounds SYNTEX (USA) Inc 12 July 1972 [12 Jan 1972 5 June 1972] 47373/74 Divided out of 1398722 Heading C2C The invention comprises compounds of the formula wherein either the X groups are identical and are -S(O) n -R groups where n is 1 or 2 and R is C 1 -C 5 alkyl or C 3 -C 5 cycloalkyl; or one X group is C 1 -C 5 alkyl or alkoxy, or C 3 -C 5 cycloalkyl or cycloalkoxy and the other X group is -S(O) n -R as above; and non-toxic esters, amides and salts thereof. They may be obtained by oxidizing a compound of one of the formulµ wherein R<SP>13</SP>, R<SP>17</SP> and R<SP>19</SP> are C 1 -C 5 alkyl or C 3 -C 5 cycloalkyl, and R<SP>16</SP> and R<SP>18</SP> are C 1 -C 5 alkyl or alkoxy, or C 3 -C 5 cycloalkyl or cycloalkoxy; or an alkyl ester thereof with a peracid or H 2 O 2 optionally followed by hydrolysis, and optionally converting the products into their non-toxic esters, amides or salts. Examples are given for the production of the compounds. Pharmaceutical compositions comprise the compounds of Formula I above which may be administered orally, topically, parenterally or by inhalation in conventional forms, optionally together with other pharmaceutical agents. They are useful for inhibiting the effects of allergic reactions, also as smooth muscle relaxants and as vasodilators. The compounds of formula (5) above are prepared by condensing a o,p-di(alkyl [or cycloalkyl] thio)phenol with a 1,3-dicarboalkoxy-4- halobenzene, in the presence of cuprous oxide, base hydrolysing the product thereof, cyclizing the hydrolysed product, optionally followed by esterification, or by the process which comprises alkylating 5,7 - dimercaptoxanthone - 2 - carboxylic acid optionally followed by hydrolysis, said 5,7 - dimercaptoxanthone - 2 - carboxylic acid being optionally prepared by: condensing o,p - dimethoxyphenol with a 1,3 - dicarboalkoxy - 4 - halobenzene, base hydrolysing the product thereof, cyclizing the hydrolysed product, hydrolysing the cyclized product to give the corresponding 5,7-dihydroxy-xanthone-2- carboxylic acid, esterifying the latter, treating the ester with a dialkylthiocarbamoyl chloride; rearranging the product thereof, base hydrolysing the rearranged product to give the 5,7- dimercaptoxanthone - 2 - carboxylic acid and treating the latter with chlorine under acidic conditions or by reducing 5,7-dimercaptoxanthone-2-carboxylic acid to the corresponding xanthene compound, treating the latter with chlorine under acidic conditions followed by oxidation. The compounds of formulµ (24) and (29) above are prepared by condensing a o-alkyl-, cycloalkyl-, cycloalkoxy or -alkoxy-p-(alkylthio)phenol or a o-alkylthio-p-alkyl- or cycloalkoxy-phenol with a 1,3-dicarboalkoxy-4-halobenzene, base hydrolysing the product thereof, and cyclizing the hydrolysed product.
GB4737374A 1972-01-12 1972-07-12 Disubstituted xanthone carboxylic acid compounds Expired GB1398724A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00217287A US3849565A (en) 1972-01-12 1972-01-12 Disubstituted xanthone carboxylic acid compounds for inhibiting asthma
US25985272A 1972-06-05 1972-06-05

Publications (1)

Publication Number Publication Date
GB1398724A true GB1398724A (en) 1975-06-25

Family

ID=26911795

Family Applications (4)

Application Number Title Priority Date Filing Date
GB4737574A Expired GB1398725A (en) 1972-01-12 1972-07-12 Disubstituted xanthone carboxylic acid compounds
GB4737374A Expired GB1398724A (en) 1972-01-12 1972-07-12 Disubstituted xanthone carboxylic acid compounds
GB4736974A Expired GB1398723A (en) 1972-01-12 1972-07-12 Chlorosulphonyl-xanthone-2-carboxylic acids
GB3253472A Expired GB1398722A (en) 1972-01-12 1972-07-12 Disbustistuted xanthone carboxylic acid compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB4737574A Expired GB1398725A (en) 1972-01-12 1972-07-12 Disubstituted xanthone carboxylic acid compounds

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB4736974A Expired GB1398723A (en) 1972-01-12 1972-07-12 Chlorosulphonyl-xanthone-2-carboxylic acids
GB3253472A Expired GB1398722A (en) 1972-01-12 1972-07-12 Disbustistuted xanthone carboxylic acid compounds

Country Status (15)

Country Link
JP (4) JPS5347107B2 (en)
AR (5) AR202889A1 (en)
AT (2) AT327897B (en)
AU (1) AU465362B2 (en)
BE (1) BE793749A (en)
CA (1) CA1014167A (en)
CH (4) CH586694A5 (en)
DE (1) DE2265054A1 (en)
ES (6) ES404790A1 (en)
FR (1) FR2167490B1 (en)
GB (4) GB1398725A (en)
IL (1) IL39891A (en)
NL (1) NL7209629A (en)
NO (3) NO137199C (en)
SE (1) SE387946B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1010719A3 (en) 1996-10-28 1998-12-01 Dsm Nv Process for the preparation of hydroxylammonium.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759292A (en) * 1969-11-27 1971-05-24 Allen & Hanburys Ltd XANTHONE DERIVATIVES, THEIR PREPARATION AND THEIR USE

Also Published As

Publication number Publication date
CH586692A5 (en) 1977-04-15
JPS5350171A (en) 1978-05-08
NO137199B (en) 1977-10-10
JPS4880565A (en) 1973-10-29
FR2167490A1 (en) 1973-08-24
SE387946B (en) 1976-09-20
AU4445872A (en) 1974-01-17
NO137204C (en) 1978-01-18
AR202889A1 (en) 1975-07-31
CA1014167A (en) 1977-07-19
CH586694A5 (en) 1977-04-15
JPS5350172A (en) 1978-05-08
AT327898B (en) 1976-02-25
ES433554A1 (en) 1976-12-01
NO137204B (en) 1977-10-10
AU465362B2 (en) 1975-09-25
AR206878A1 (en) 1976-08-31
JPS5347107B2 (en) 1978-12-19
IL39891A (en) 1976-01-30
GB1398725A (en) 1975-06-25
NL7209629A (en) 1973-07-16
FR2167490B1 (en) 1975-08-08
ES433552A1 (en) 1976-12-01
CH588483A5 (en) 1977-06-15
GB1398723A (en) 1975-06-25
ATA860674A (en) 1975-05-15
BE793749A (en) 1973-07-09
CH586693A5 (en) 1977-04-15
NO137203B (en) 1977-10-10
AT327897B (en) 1976-02-25
DE2265054A1 (en) 1976-02-05
ES433553A1 (en) 1976-12-01
AR206919A1 (en) 1976-08-31
ES435108A1 (en) 1977-03-16
AR202188A1 (en) 1975-05-23
GB1398722A (en) 1975-06-25
ATA860574A (en) 1975-05-15
AR208274A1 (en) 1976-12-20
NO137203C (en) 1978-01-18
NO137199C (en) 1978-01-18
IL39891A0 (en) 1972-09-28
JPS5350170A (en) 1978-05-08
ES404790A1 (en) 1975-11-16
ES433555A1 (en) 1977-02-16

Similar Documents

Publication Publication Date Title
GB1391005A (en) 1,3,4,9-tetrahydro-pyrano or thiopyrano- 3,4-b indole derivatives
GB1348199A (en) Acylaminopenicillanic acid derivatives
US2479297A (en) Process and culture media for producing new penicillins
NO861449L (en) PROCEDURE FOR THE PREPARATION OF ANTIBACTERIAL QUINOLIN-3 CARBOXYLIC ACID COMPOUNDS.
GB1196229A (en) Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same
GB1353326A (en) 8-oxo-5-thia-1-azabicyclo-4,2,0-oct-2-ene compounds process for their manufacture and compositions containing them
GB1398724A (en) Disubstituted xanthone carboxylic acid compounds
FR2272684A1 (en) Antibiotic-unsaturated acid compsns. - having a synergistic effect against gram positive and negative bacteria
GB1469350A (en) Carboxy-phenol-alkylphosphinic acids their esters and process for their preparation
IL37467A (en) Derivatives of benzopyran-2-carboxylic acid,their preparation and pharmaceutical compositions containing them
GB1357449A (en) Furoquinolinecarboxylic acid derivatives
US3470151A (en) Furyl- and thienyl-penicillins and salts thereof
JPS56118085A (en) 2-methylcephalosporin derivative and its preparation
GB1398096A (en) Substituted xanthone carboxylic acid compounds
GB1394584A (en) Heterocyclic substituted xanthone carboxylic acid compounds
GB1385404A (en) Disubstituted xanthone carboxylic acid compounds
JPS57106651A (en) 1,4-disubstituted benzene compound, its preparation, and inhibitor against leukotriene biosynthesis comprising it as active ingredient
GB1464561A (en) Disubstituted xanthone carboxylic acid compounds
GB1393413A (en) Heterocyclic substituted xanthone carboxylic acid compounds
GB1394385A (en) Substituted xanthone carboxylic acid compounds
GB1411700A (en) Penicillins and production thereof
GB1355872A (en) Phosphono substituted alkylcephalosporins
GB1384145A (en) Disubstituted xanthone carboxylic acid compounds
GB1386436A (en) Xanthone carboxylic acids and derivatives
ATE48836T1 (en) PROCESS FOR THE MANUFACTURE OF ANTIBACTERIAL QUINOLINE-3-CARBONIC ACID MATERIALS.

Legal Events

Date Code Title Description
429A Application made for amendment of specification (sect. 29/1949)
429H Application (made) for amendment of specification now open to opposition (sect. 29/1949)
429D Case decided by the comptroller ** specification amended (sect. 29/1949)
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee